Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Yuji Hosono; Brandon Sie; Iago Pinal-Fernandez; Katherine Pak; Christopher A Mecoli; Maria Casal-Dominguez; Blake M Warner; Mariana J Kaplan; Jemima Albayda; Sonye Danoff; Thomas E Lloyd; Julie J Paik; Eleni Tiniakou; Rohit Aggarwal; Chester V Oddis; Siamak Moghadam-Kia; Carmelo Carmona-Rivera; Jose César Milisenda; Josep Maria Grau-Junyent; Albert Selva-O'Callaghan; Lisa Christopher-Stine; H Benjamin Larman; Andrew Lee Mammen

doi:10.1136/ard-2022-222441

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

Myositis

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password